Rebecca L. Schneider PhD
The Child OCD Program at Emory (COPE) is a telehealth-based intensive outpatient program for adolescents ages 12-18 with OCD. The program involves 10 hours per week of group, family, and individual treatment for OCD, including ACT and DBT-based skills groups and daily ERP.
Our program uses exposure and response prevention (ERP), acceptance and commitment therapy (ACT), and dialectical behavior therapy (DBT) to treat OCD and co-occurring disorders, including (but not limited to) depression, anxiety, emotion dysregulation, and disordered eating.
I specialize in providing evidence-based treatment for OCD, anxiety, and misophonia in youth. I received my PhD from the University of Colorado Boulder, where my clinical and research work focused on acceptance and commitment therapy (ACT) for anxiety. I completed my internship at Stanford Children’s Hospital, and my postdoctoral fellowship at the Child and Adolescent OCD Institute (OCDI Jr.) at McLean Hospital/Harvard Medical School. I currently direct an intensive treatment program for adolescents with OCD at Emory University School of Medicine. I have experience treating youth across all levels of care, including outpatient, intensive outpatient, partial hospitalization, inpatient, and residential.
We strive to make evidence-based care as accessible as possible. Having a telehealth-based IOP allows us to provide treatment to adolescents across the state of Georgia, including those in communities where OCD providers are not readily available. In addition, our program accepts most major insurances, some forms of Medicaid, and offers a sliding scale for uninsured or self-pay families.
Our intensive outpatient program involves daily ERP groups, along with weekly ACT, DBT, multifamily, and support groups.